Opportunistic Infections Citation List:
October 1 - October 14, 2010
OPPORTUNISTIC PROTOZOA COMPOUNDS (including pneumocystis, cryptosporidium, toxoplasma, microsporidia [encephalitozoon, enterocytozoon, vittaforma])
1.Carbocyclic 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase: biological activities and selective toxicities. Al Safarjalani, O.N., R.H. Rais, Y.A. Kim, C.K. Chu, F.N. Naguib, and M.H. El Kouni. Biochemical Pharmacology, 2010. 80(7): p. 955-963; PMID[20541538].
[Pubmed]. OI_1001-101410.
ANTIFUNGAL COMPOUNDS ( includes Cryptococcus, Aspergillus, Candida, & Histoplasma)
2.In Vitro Antifungal Activity of Dihydroxyacetone Against Causative Agents of Dermatomycosis. Stopiglia, C.D., F.J. Vieira, A.G. Mondadori, T.P. Oppe, and M.L. Scroferneker. Mycopathologia, 2010; [Epub ahead of print]. PMID[20936361].
[Pubmed]. OI_1001-101410.
3. Synthesis and antimicrobial activities of novel 1H-dibenzo[a,c]carbazoles from dehydroabietic acid. Gu, W. and S. Wang. European Journal of Medicinal Chemistry, 2010. 45(10): p. 4692-4696; PMID[20702006].
[Pubmed]. OI_1001-101410.
4. Synthesis of novel sulfanilamide-derived 1,2,3-triazoles and their evaluation for antibacterial and antifungal activities. Wang, X.L., K. Wan, and C.H. Zhou. European Journal of Medicinal Chemistry, 2010. 45(10): p. 4631-4639; PMID[20708826].
[Pubmed]. OI_1001-101410.
5. 2-, 3-, and 4-(1-Oxo-1H-2,3-dihydroisoindol-2-yl)benzoic acids and their corresponding organotin carboxylates: synthesis, characterization, fluorescent, and biological activities. Cai, S.L., Y. Chen, W.X. Sun, H. Li, and S.S. Yuan. Bioorganic & Medicinal Chemistry Letters, 2010. 20(19): p. 5649-5652; PMID[20801655].
[Pubmed]. OI_1001-101410.
6. In vitro synergy of eugenol and methyleugenol with fluconazole against clinical Candida isolates. Ahmad, A., A. Khan, L.A. Khan, and N. Manzoor, In vitro synergy of eugenol and methyleugenol with fluconazole against clinical Candida isolates. Journal of Medical Microbiology, 2010. 59(Pt 10): p. 1178-1184; PMID[20634332].
[Pubmed]. OI_1001-101410.
7. In vitro activity of isavuconazole against 140 reference fungal strains and 165 clinically isolated yeasts from Japan. Yamazaki, T., Y. Inagaki, T. Fujii, J. Ohwada, M. Tsukazaki, I. Umeda, K. Kobayashi, N. Shimma, M.G. Page, and M. Arisawa. International Journal of Antimicrobial Agents, 2010. 36(4): p. 324-331; PMID[20674282].
[Pubmed]. OI_1001-101410.
8. Mammalian cell toxicity and candidacidal mechanism of Arg- or Lys-containing Trp-rich model antimicrobial peptides and their d-enantiomeric peptides. Nan, Y.H., S.H. Lee, H.J. Kim, and S.Y. Shin. Peptides, 2010. 31(10): p. 1826-1831; PMID[20621141].
[Pubmed]. OI_1001-101410.
9. Inhibition of fungi and gram-negative bacteria by bacteriocin BacTN635 produced by Lactobacillus plantarum sp. TN635. Smaoui, S., L. Elleuch, W. Bejar, I. Karray-Rebai, I. Ayadi, B. Jaouadi, F. Mathieu, H. Chouayekh, S. Bejar, and L. Mellouli. Applied Biochemistry and Biotechnology, 2010. 162(4): p. 1132-1146; PMID[19888697].
[Pubmed]. OI_1001-101410.
ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)
10. Schiff bases of indoline-2,3-dione (isatin) derivatives and nalidixic acid carbohydrazide, synthesis, antitubercular activity and pharmacophoric model building. Aboul-Fadl, T., F.A. Bin-Jubair, and O. Aboul-Wafa. European Journal of Medicinal Chemistry, 2010. 45(10): p. 4578-4586; PMID[20696500].
[Pubmed]. OI_1001-101410.
11. Isoxazole analogs of curcuminoids with highly potent multidrug-resistant antimycobacterial activity. Changtam, C., P. Hongmanee, and A. Suksamrarn. European Journal of Medicinal Chemistry, 2010. 45(10): p. 4446-4457; PMID[20691508].
[Pubmed]. OI_1001-101410.
12. E-2-[3-(3,4-dichlorophenyl)-1-oxo-2-propenyl]-3-methylquinoxaline-1,4-diox ide: a lead antitubercular agent which alters mitochondrial respiration in rat liver. Das, U., S. Das, B. Bandy, D.K. Gorecki, and J.R. Dimmock. European Journal of Medicinal Chemistry, 2010. 45(10): p. 4682-4686; PMID[20705367].
[Pubmed]. OI_1001-101410.
13.Development of isoniazid-NAD truncated adducts embedding a lipophilic fragment as potential bi-substrate InhA inhibitors and antimycobacterial agents . Delaine, T., V. Bernardes-Genisson, A. Quemard, P. Constant, B. Meunier, and J. Bernadou. European Journal of Medicinal Chemistry, 2010. 45(10): p. 4554-4561; PMID[20696503].
[Pubmed]. OI_1001-101410.
14. Anti-tubercular screening of natural products from Colombian plants: 3-methoxynordomesticine, an inhibitor of MurE ligase of Mycobacterium tuberculosis. Guzman, J.D., A. Gupta, D. Evangelopoulos, C. Basavannacharya, L.C. Pabon, E.A. Plazas, D.R. Munoz, W.A. Delgado, L.E. Cuca, W. Ribon, S. Gibbons, and S. Bhakta. Journal of Antimicrobial Chemotherapy, 2010. 65(10): p. 2101-2107; PMID[20719764].
[Pubmed]. OI_1001-101410.
15. Anti-tubercular agents. Part 5: synthesis and biological evaluation of benzothiadiazine 1,1-dioxide based congeners. Kamal, A., R.V. Shetti, S. Azeeza, S.K. Ahmed, P. Swapna, A.M. Reddy, I.A. Khan, S. Sharma, and S.T. Abdullah. European Journal of Medicinal Chemistry, 2010. 45(10): p. 4545-4553; PMID[20705368].
[Pubmed]. OI_1001-101410.
16. Synthesis and antitubercular activity of heterocycle substituted diphenyl ether derivatives. Kini, S.G., A. Bhat, Z. Pan, and F.E. Dayan. Journal of Enzyme Inhibition and Medicinal Chemistry, 2010. 25(5): p. 730-736; PMID[20443682].
[Pubmed]. OI_1001-101410.
17. New amino acid esters of salicylanilides active against MDR-TB and other microbes. Kratky, M., J. Vinsova, V. Buchta, K. Horvati, S. Bosze, and J. Stolarikova. European Journal of Medicinal Chemistry, 2010; [Epub ahead of print]. PMID[20937542].
[Pubmed]. OI_1001-101410.
18. Evaluation of flavonoids from Dorstenia barteri for their antimycobacterial, antigonorrheal and anti-reverse transcriptase activities. Kuete, V., B. Ngameni, A.T. Mbaveng, B. Ngadjui, J.J. Meyer, and N. Lall. Acta Tropica, 2010. 116(1): p. 100-104; PMID[20599632].
[Pubmed]. OI_1001-101410.
19. Leads for antitubercular compounds from kinase inhibitor library screens. Magnet, S., R.C. Hartkoorn, R. Szekely, J. Pato, J.A. Triccas, P. Schneider, C. Szantai-Kis, L. Orfi, M. Chambon, D. Banfi, M. Bueno, G. Turcatti, G. Keri, and S.T. Cole. Tuberculosis (Edinburg), 2010; [Epub ahead of print]. PMID[20934382].
[Pubmed]. OI_1001-101410.
20. Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives. Moreno, E., S. Ancizu, S. Perez-Silanes, E. Torres, I. Aldana, and A. Monge. European Journal of Medicinal Chemistry, 2010. 45(10): p. 4418-4426; PMID[20656380].
[Pubmed]. OI_1001-101410.
21. Synthesis and structure of azole-fused indeno[2,1-c]quinolines and their anti-mycobacterial properties. Upadhayaya, R.S., P.D. Shinde, A.Y. Sayyed, S.A. Kadam, A.N. Bawane, A. Poddar, O. Plashkevych, A. Foldesi, and J. Chattopadhyaya. Organic and Biomolecular Chemistry, 2010; [Epub ahead of print]. PMID[20927480].
[Pubmed]. OI_1001-101410.
Citations from the ISI Web of Knowledge Listings for O.I.
22. Synthesis of novel 1,3,4-oxadiazole derivatives as potential antimicrobial agents. Chawla, R., A. Arora, M.K. Parameswaran, P. Chan-Der Sharma, S. Michael, and T.K. Ravi. Acta Poloniae Pharmaceutica, 2010. 67(3): p. 247-253; ISI[000281750900005].
[WOS]. OI_1001-101410.
23. Activity of beta-lapachone derivatives against rifampicin-susceptible and -resistant strains of Mycobacterium tuberculosis. Coelho, T.S., R.S.F. Silva, A.V. Pinto, M. Pinto, C.J. Scaini, K.C.G. Moura, and P.A. da Silva. Tuberculosis, 2010. 90(5): p. 293-297; ISI[000282144100002].
[WOS]. OI_1001-101410.
24. Novel dihydropyrimidines as a potential new class of antitubercular agents. Trivedi, A.R., V.R. Bhuva, B.H. Dholariya, D.K. Dodiya, V.B. Kataria, and V.H. Shah. Bioorganic & Medicinal Chemistry Letters, 2010. 20(20): p. 6100-6102; ISI[000281963700032].
[WOS]. OI_1001-101410.
25.In Vivo Efficacy of Anidulafungin against Mature Candida albicans Biofilms in a Novel Rat Model of Catheter-Associated Candidiasis Kucharikova. Kucharikova, S., H. Tournu, M. Holtappels, P. Van Dijck, and K. Lagrou. Antimicrobial Agents and Chemotherapy, 2010. 54(10): p. 4474-4475; ISI[000281907200058].
[WOS]. OI_1001-101410.
26. Novel Chromeneimidazole Derivatives as Antifungal Compounds: Synthesis and In Vitro Evaluation. Thareja, S., A. Verma, A. Kalra, S. Gosain, P.V. Rewatkar, and G.R. Kokil. Acta Poloniae Pharmaceutica, 2010. 67(4): p. 423-427; ISI[000281751000014].
[WOS]. OI_1001-101410.